Close collaboration between surgeon and pathologist is essential for accurate staging of early colon cancer.

A. Bilchik,C. Compton
DOI: https://doi.org/10.1097/SLA.0B013E31805D07E3
IF: 13.787
2007-06-01
Annals of Surgery
Abstract:The postoperative rate of recurrence for stage II colon cancer exceeds 20%, and evidence suggests that some patients with stage II disease have a worse prognosis than those with stage III disease.1 If patients with high-risk stage II disease could be accurately identified, they might benefit from postoperative chemotherapy, a treatment that is highly effective for metastatic disease but too toxic and expensive for routine use in node-negative colon cancer. Unfortunately, while the prognostic importance of lymph node status is undisputed, there is no consensus or standardization of techniques for sampling and assessment of lymph nodes in a resected specimen. Which and how many nodes should be sampled? How should these nodes be assessed for tumor? What is the clinical significance of micrometastases in the lymph nodes?
What problem does this paper attempt to address?